期刊文献+

索利那新联合雌三醇软膏治疗绝经后女性膀胱过度活动症的疗效 被引量:7

下载PDF
导出
摘要 膀胱过度活动症( overactive bladder symptom , OAB)以尿急症状为特征,常伴有尿频和夜尿症状,可伴或不伴有急迫性尿失禁。尿动力学上表现为逼尿肌过度活动,无明确病因,不包括由急性尿路感染或其他形式的膀胱尿道局部病变所致的症状。 OAB是老年妇女常见病,研究显示索利那新治疗女性OAB疗效显著,不良反应少,并可显著改善患者的生活质量。考虑到老年女性OAB与绝经后内分泌失调引起的尿道末端萎缩性变化有关,因此作者采用索利那新联合雌激素治疗方案对绝经后女性OAB患者120例进行治疗,效果显著,报道如下。
出处 《郑州大学学报(医学版)》 CAS 北大核心 2014年第5期752-754,共3页 Journal of Zhengzhou University(Medical Sciences)
  • 相关文献

参考文献12

  • 1刘洁,张维怡,柳应旭,丁德刚,石红林,杜广辉.索利那新治疗女性中重度膀胱过度活动症的疗效观察[J].中华泌尿外科杂志,2013,34(1):74-74. 被引量:6
  • 2杨尚琪,来永庆,陈月英,池泽湃,任瑞,王亚东,魏灿,倪梁朝,关志忱.膀胱过度活动症症状评分表评估膀胱过度活动症的临床研究[J].中华临床医师杂志(电子版),2012,6(16):4675-4678. 被引量:24
  • 3Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score [ J ]. Urology, 2006,68 ( 2 ) : 318. 被引量:1
  • 4许克新,汪磊,王晓峰,那彦群,叶章群,黄翼然,宋波,孔垂泽.膀胱过度活动症症状评分表对中国OAB患者结果评估的重复信度及与其他症状评分工具间相关性的研究[J].中华泌尿外科杂志,2010,31(11):727-731. 被引量:102
  • 5那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2013:439. 被引量:49
  • 6Takao T, Tsujimura A, Yamamoto K, et al. Solifenacin may improve sleep quality in patients with overactive bladder and sleep disturbance[J].. Urology,2011,78 ( 3 ) :648. 被引量:1
  • 7But I,Goldstajn MS,Oreskovic S. Comparison of two selec- tive muscarinic receptor antagonists(solifenacin and darife- nacin) in women with overactive bladder: the SOLIDAR study [J].Coll Antropol, 2012,36 (4) : 1347. 被引量:1
  • 8Swift SE, Siami P, Forero-Schwanhaeuser S. Diary and pa- tient-reported outcomes in patients with severe overactive bladder switching from toherodine extended release 4 mg/ day to solifenacin treatment : an open-label, flexible-dosing, muhicentre study[J].- Clin Drug Investig, 2009,29 ( 5 ) : 305. 被引量:1
  • 9Herschorn S, Pommerville P, Stothers L, et al. Tolerability of solifenacin and oxybutynin immediate release in older ( > 65 years)and younger( < 65 years)patients with over- active bladder: sub-analysis from a Canadian, randomized, double-blind study[J]. Curr Med Res Opin, 2011,27 ( 2 ) : 375. 被引量:1
  • 10Burger M, Betz D, Hampel C, et al. Efficacy and tolerabili- ty of solifenacin in men with overactive bladder: results of an observational study [ J]. World J Urol, 2013 Oct 18 [ Epub ahead of print]. 被引量:1

二级参考文献26

  • 1Leone Roberti Maggiore U, Salvatore S, Alessandri F, et al. Pharmacokinetics and toxicity of antimuscarinlc drugs for overactive bladder treatment in females. Expert Opin Drug Metab Toxicol, 2012, 8 : 1387-1408. 被引量:1
  • 2Takao T, Tsujimura A, Yamamoto K, et al. Solifenaein may improve sleep quality in patients with overactive bladder and sleep disturbance. Urology, 2011, 78: 648-652. 被引量:1
  • 3Hersehorn S, Pommerville P, Stothers L, et ak Tolerability of solifenacin and oxy- butynin immediate release in older ( > 65 years) and younger ( 65 years) patients withoveractive bladder: sub-analysis from a Canadian, randomized, double-blind study. Curr Med Res Opin, 2011, 27: 375-382. 被引量:1
  • 4Luo D, Liu L, Han P, et al. Solifenacin for overactive bladder: a systematic review and meta-analysis. Int Urogynecol J, 2012, 23: 953-991. 被引量:1
  • 5Abrams P;Cardozo L;Fall M.The standardisation of terminology of lower urinary tract function:report from the Standardisation Sub-Committee of the International Continence Society,2002. 被引量:1
  • 6Herbison P;Hay-Smith J;Ellis G.Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder:systematic review,2003. 被引量:1
  • 7Homma Y;Paick JS;Lee JG.Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder:a randomized,placebo-controlled trial,2003. 被引量:1
  • 8Milsom I;Abrams P;Cardozo L.How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study,2001. 被引量:1
  • 9Coyne K;Revicki D;Hunt T.Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire:the OAB-q,2002. 被引量:1
  • 10Matza LS;Thompson CL;Krasnow J.Test-retest reliability of four questionnaires for patients with overactive bladder:the overactive bladder questionnaire(OAB-q),patient perception of bladder condition(PPBC),urgency questionnaire(UQ),and the primary OAB symptom questionnaire(POSQ),2005. 被引量:1

共引文献170

同被引文献53

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部